Open AccessEffectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial
Author(s) -
Catriona Jennings,
Kornelia Kotseva,
Dirk De Bacquer,
Arno W. Hoes,
J De Velasco,
Silvio Brusaferro,
A Mead,
Joanne Jones,
Serena Tonstad,
David Wood
Publication year - 2014
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehu051
Subject(s) - medicine , varenicline , smoking cessation , randomized controlled trial , clinical endpoint , blood pressure , risk factor , abstinence , physical therapy , nicotine , pathology , psychiatry
The EUROACTION PLUS trial measured the effectiveness of a nurse-led preventive cardiology programme (EUROACTION) offering intensive smoking cessation PLUS optional varenicline for persistent high CVD risk smokers to reduce overall cardiovascular risk compared with usual care (UC) in general practice (GP).